Research Article
The Clinical Significance of PR, ER, NF-κB, and TNF-α in Breast Cancer
Table 2
Immunohistochemical reactivity of PR, ER, NF-
κB, and TNF-
(
).
| Parameters | Expression | Cancer tissue (%) | Normal tissue (%) | | value |
| ER | + | 85 (76) | 17 (15) | 83.23 | <0.0001 | − | 27 (24) | 95 (85) |
| PR | + | 75 (67) | 20 (18) | 55.29 | <0.0001 | − | 37 (33) | 92 (82) |
| NF-κB | + | 94 (84) | 0 (0) | 162.0 | <0.0001 | − | 18 (16) | 112 (100) |
| TNF- | + | 105 (94) | 2 (2) | 189.8 | <0.0001 | − | 7 (6) | 110 (98) |
|
|
PR: progesterone receptor; ER: estrogen receptor; NF-κB: nuclear factor-κB; TNF-α: tumor necrosis factor-.
|